CLINICAL_TRIALS trial_result · 2021-03-26

Clinical Trial Update: A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia [Phase 2]

A Phase 2 trial assessing efficacy and safety of OCV-501 in elderly patients with Acute Myeloid Leukemia has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2021-03-26